STAT

Trump proposes importing medicines, but he’s really seeking a quick political hit

The new White House plan to import medicines from Canada is being billed as historic, but you better gas up if you think the proposal will save you from making a trip across the border to buy insulin.

Along with some other medicines known as biologics, which are typically administered by physicians, the diabetes treatment will not be part of the new proposal announced on Wednesday. Neither will many cancer medicines. And this is just one of several limitations to a plan that, in all fairness, holds some potential, but appears politically motivated more than anything else.

This is among the reasons I think the plan will have, at best, a modest impact. But before I delve into the nitty-gritty, let’s look at the politics.

Timing, of course, is everything and when it comes to prescription drugs, President Trump needs

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks